Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

32.42USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$32.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
455,448
52-wk High
$45.02
52-wk Low
$13.13

Chart for

About

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly... (more)

Overall

Beta: --
Market Cap(Mil.): $1,043.82
Shares Outstanding(Mil.): 41.74
Dividend: --
Yield (%): --

Financials

  EDIT.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -3.19 -- --
ROI: -42.42 1.58 14.38
ROE: -63.35 2.41 16.07

BRIEF-Editas Medicine Names James Mullen As Chairman Of Board

* EDITAS MEDICINE NAMES JAMES C. MULLEN AS CHAIRMAN OF THE BOARD OF DIRECTORS

28 Mar 2018

BRIEF-Editas Medicine Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing‍​

* EDITAS MEDICINE INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text (http://bit.ly/2GlXQp9) Further company coverage: (Reuters.Brief@thomsonreuters.com)

12 Mar 2018

BRIEF-Editas Medicine Q4 Loss Per Share $0.84

* EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND UPDATE

06 Mar 2018

BRIEF-Adverum Biotechnologies Extends Collaboration Agreement With Editas Medicine

* ANNOUNCES EXTENSION OF ITS COLLABORATION AGREEMENT WITH EDITAS MEDICINE INC

25 Jan 2018

BRIEF-Editas Medicine Files For Potential Stock Shelf, Size Undisclosed - SEC Filing

* EDITAS MEDICINE INC FILES FOR POTENTIAL STOCK SHELF, SIZE UNDISCLOSED - SEC FILING Source text: (http://bit.ly/2zhhSfB) Further company coverage:

22 Dec 2017

BRIEF-Editas Medicine Announces Pricing Of $50 Mln Offering Of Common Stock

* EDITAS MEDICINE, INC., ANNOUNCES PRICING OF $50 MILLION OFFERING OF COMMON STOCK

06 Dec 2017

BRIEF-Editas Medicine Announces Offering Of Common Stock

* EDITAS MEDICINE INC - INTENDS TO OFFER AND SELL $50 MILLION OF SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING Source text for Eikon: Further company coverage:

05 Dec 2017

BRIEF-Editas Medicine announces Q3 loss per share $0.64

* Editas Medicine announces third quarter 2017 results and update

07 Nov 2017

Earnings vs. Estimates